Phio Pharmaceuticals Corp. Quarterly Nonoperating Income (Expense) in USD from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Phio Pharmaceuticals Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2014 to Q3 2024.
  • Phio Pharmaceuticals Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $66K.
  • Phio Pharmaceuticals Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $193K.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2023 was -$2K, a 88.9% increase from 2022.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2022 was -$18K, a 108% decline from 2021.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2021 was $224K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $193K $66K +$70K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $123K $68K +$70K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $53K $55K +$55K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$2K $4K +$5K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$7K -$4K +$1K +20% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$8K -$2K +$8K +80% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$16K $0 +$2K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$18K -$1K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$18K -$5K -$2K -66.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$16K -$10K -$7K -233% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$9K -$2K -$233K -101% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $224K -$1K -$1K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $225K -$3K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $225K -$3K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $225K $231K +$226K +4520% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$1K $0 -$9K -100% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $8K -$3K -$22K -116% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $30K -$3K -$27K -113% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $57K $5K -$22K -81.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $79K $9K +$2K +28.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $77K $19K +$20K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $57K $24K +$26K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $31K $27K +$27K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $4K $7K +$18K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$14K -$1K -$1K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$13K -$2K -$2K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$11K $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$11K -$11K -$11K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-27
Q3 2017 $0 $0 -$4K -100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $4K $0 -$3K -100% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $7K $0 -$14K -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $21K $0 -$6K -100% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-26
Q3 2016 $27K $4K -$4K -50% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-03-26
Q2 2016 $31K $3K +$4K Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-03-26
Q1 2016 $27K $14K +$13K +1300% Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-03-26
Q4 2015 $14K $6K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $8K +$5K +167% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$1K -$16K -107% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $1K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 $3K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $15K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.